Prostate Cancer, Version 3.2024.

Edward M Schaeffer,Sandy Srinivas,Nabil Adra,Yi An,Rhonda Bitting,Brian Chapin,Heather H Cheng, Anthony Victor D'Amico,Neil Desai,Tanya Dorff,James A Eastham,Thomas A Farrington, Xin Gao,Shilpa Gupta,Thomas Guzzo,Joseph E Ippolito,R Jeffrey Karnes,Michael R Kuettel,Joshua M Lang,Tamara Lotan,Rana R McKay,Todd Morgan, Julio M Pow-Sang,Robert Reiter,Mack Roach,Tyler Robin,Stan Rosenfeld,Ahmad Shabsigh,Daniel Spratt, Russell Szmulewitz,Benjamin A Teply,Jonathan Tward,Richard Valicenti,Jessica Karen Wong, Jenna Snedeker, Deborah A Freedman-Cass

Journal of the National Comprehensive Cancer Network : JNCCN（2024）

引用 0|浏览7

暂无评分

摘要

The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要